prostate cancer
Conditions
Interventions
observational study:non-interventional
Sponsors
Chinese PLA general hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Men aged = 18 years and < 75 years. (2) Histologically or cytologically confirmed prostate cancer; (3) Eastern Cooperative Oncology Group (ECOG) performance status score = 1, life expectancy = 10 years; (4) No other cancer chemotherapy history, no chemotherapy, no endocrine therapy contraindications. (5) The subjects voluntarily participate, and the subjects themselves must sign the informed consent form (ICF), indicating that they understand the purpose of this study and the required procedures, and are willing to participate in the study. Subjects must be willing and comply with prohibitions and restrictions specified in the study protocol.
Exclusion criteria
Exclusion criteria: (1) Prostate pathology shows neuroendocrine prostate cancer, including small cell carcinoma. (2) Other situations where the investigator considers as inappropriate for the subjects to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to mCRPC; | — |
Countries
China
Contacts
Public ContactWang Baojun
Chinese PLA general hospital
Outcome results
None listed